Abstract
Diablo/Smac is a mammalian pro-apoptotic protein that can antagonize the inhibitor of apoptosis proteins (IAPs). We have produced monoclonal antibodies specific for Diablo and have used these to examine its tissue distribution and subcellular localization in healthy and apoptotic cells. Diablo could be detected in a wide range of mouse tissues including liver, kidney, lung, intestine, pancreas and testes by Western blot analysis. Immunohistochemical analysis found Diablo to be most abundant in the germinal cells of the testes, the parenchymal cells of the liver and the tubule cells of the kidney. In support of previous subcellular localization analysis, Diablo was present within the mitochondria of healthy cells, but released into the cytosol following the induction of apoptosis by UV.
Similar content being viewed by others
Introduction
Apoptosis in insects and vertebrates can be controlled by inhibitor of apoptosis proteins (IAPs) that act by directly binding to activated caspases. In Drosophila, the IAPs (DIAP1 and DIAP2) are antagonized by three pro-apoptotic proteins, Grim, HID and Reaper, which bind to them, thereby displacing the active caspases.1,2,3,4 In mammals, Diablo/Smac was the first protein shown to bind and antagonize IAPs.5,6 Recently, HtrA2, another mammalian protein, that has an N-terminus similar to that of Grim, Reaper, HID and Diablo, has been shown to bind and antagonize IAP function.7,8,9,10 Unlike Grim, HID and Reaper, Diablo/Smac localizes to the inter-membrane space of the mitochondria in healthy cells.5,6 Upon receipt of certain apoptotic stimuli, Diablo is released from the mitochondria, and in the cytosol it is able to bind and antagonize IAPs such as MIHA/XIAP.5,6
Diablo is synthesized in the cytoplasm as a larger precursor protein with an N-terminal mitochondrial targeting peptide that is removed upon importation into the mitochondria.5,6 This processing produces an N-terminus of Diablo beginning with the residues AVP… that resembles the N-termini of Grim, Reaper and HID, which are critical for their activity.11,12,13,14 It is via these N-terminal residues that these pro-apoptotic proteins bind to the core of the baculoviral IAP repeat (BIR) domains of IAPs.11,12,14 Through its interaction with MIHA/XIAP, Diablo can promote apoptosis by removing inhibition of MIHA/XIAP on processed caspases 3, 7 and 9.11,15,16
To determine where Diablo acts we wished to determine its tissue localization. To do this we have generated a series of monoclonal antibodies (mAbs) that can be used in tissue immunoblotting and histochemistry. Our studies show that Diablo is present in cell lines of different kinds and is detectable by immunohistochemistry in the testes, kidney and liver.
Results
Characterization of the monoclonal antibodies
Immunization of rats with mouse recombinant Diablo followed by fusion of spleen cells with the myeloma cell line SP2/0 yielded several hybridoma clones producing mAb specific for Diablo. The hybridoma clones secreting the mAb, against Diablo, were identified by flow cytometric analysis of 293T cells over-expressing HA Diablo (see Materials and Methods). Figure 1A is the staining profile of the transfected 293T cells incubated with secondary antibody alone (dotted line) or together with hybridoma supernatant which showed no immunoreactivity to Diablo (solid line). Hybridoma clones producing mAb specific for Diablo yielded a profile (Figure 1C,D) similar to the one produced when anti-HA antibody was used to detect the over-expressed HA Diablo (Figure 1B), which serves as a positive control. From an initial screen of 2000 hybridoma cultures, 20 anti-Diablo mAb generating hybridoma clones giving a profile similar to Figure 1C,D were selected for further analysis. Here we report characterization of two selected mAbs, 10G7 and 9H10. These mAbs were isotyped to be rat IgG2a, and were purified using protein-G affinity columns. They were tested for applications including Western blot analysis, immunohistochemistry, immunocytochemistry and immunoprecipitation (Table 1).
The specificity of 10G7 and 9H10
Equal amounts of protein from various human and mouse cell lines was analyzed directly or after immunoprecipitation using either 10G7 or 9H10. Lysate from 293T cells over-expressing HA Diablo and probed with either of the mAb was used as size control.
Western blot and immunoprecipitation analysis of lysates from various cell lines demonstrated that 10G7 recognizes both human and mouse Diablos (Figures 2A and 3). The membrane was re-probed with anti-HA antibody to detect the over-expressed HA Diablo in lanes 6 and 7 (Figure 2B). Due to over-expression and possible overloading of the mitochondrial processing mechanisms, the transfected cells show a band for unprocessed Diablo in addition to processed HA Diablo band (23 kD), which is similar to the endogenous Diablo. The processed HA Diablo runs slower than the endogenous Diablo presumably due to addition of the 9 residue HA tag. Under similar conditions 9H10 is specific for mouse Diablo (Figure 4A). 9H10 did not detect Diablo in the three human cell lines studied here. Equal protein loading from all cell lines was demonstrated by re-probing the blots with antibody specific to Hsp70 (Figures 2C and 4B).
Expression of Diablo in mouse tissues
Endogenous mouse Diablo was detected in various tissues by Western blot and immunoprecipitation (Figures 5A and 6) using 9H10. Testes showed the highest level of expression, followed by moderate expression in kidney, liver, intestine, lung and pancreas (Figures 5A and 6). Heart also showed a low level of Diablo (although not obvious in the figure shown here). There was no visible Diablo expression in brain (Figures 5A and 6). In other tissues such as thymus, spleen and skeletal muscle Diablo was not detectable by Western analysis (data not included).
The expression pattern of Diablo in mouse tissues was also investigated by immunohistochemistry using 9H10 mAb (Figure 7). Consistent with the results obtained by immunoblotting, Diablo was most abundant in the testes. Intense Diablo immunostaining was observed in the germinal epithelium of seminiferous tubules but not in the Leydig cells of interstitium. Staining was intense in the cytoplasm of primary spermatocytes, secondary spermatocytes and spermatids (Figure 7C). In the kidney, Diablo was most abundant in the ductal epithelia of the cortex but no immunoreactivity was detected in the glomeruli (Figure 7A). In the liver, the expression of Diablo was restricted to hepatocytes (Figure 7B).
Diablo localizes to the mitochondria
HeLa cells were transiently transfected with the full-length mouse Diablo pEF construct (see Materials and Methods) and immunofluorescence staining was performed using 9H10 followed by detection with FITC-labelled secondary antibody. The mitochondria and nuclei were co-stained using Mito Tracer Red and DAPI respectively. Analysis was performed using confocal microscopy. While the mitochondria and nuclei of all cells were stained, 9H10 only detected mouse Diablo in the cells transfected with the mouse Diablo construct. Under the conditions used here, 9H10 does not react with endogenous human Diablo in HeLa cells (Figure 8A,B). Furthermore, in healthy cells (Figure 8A) most of the Diablo co-localized within the mitochondria whereas after exposure to UV, Diablo was present throughout the cell (Figure 8B). Using 10G7, distribution of endogenous human Diablo in HeLa cells showed a punctate expression consistent with mitochondrial localization (data not shown).
Discussion
Full-length Diablo (27 kD) undergoes N-terminal processing to yield a smaller (21 kD) protein.6 As seen in Figures 2A and 3, endogenous mouse Diablo seems to run slightly faster than endogenous human Diablo even though Diablo in the two species has a similar predicted molecular weight and 89% identity.
The amounts of Diablo protein in mouse tissues corelated well with the mRNA levels as previously described5,6 except in the heart, where the amount of Diablo protein seems much lower than that expected from the abundance of mRNA. Testes showed the highest levels of Diablo protein. It is possible that high expression of pro-apoptotic molecules, such as Diablo, may be responsible for conferring the high sensitivity of testicular germ cells to radiation-induced apoptosis17,18 however Diablo was not abundant in the thymus, where cell turn over is also high and cells are similarly sensitive to radiation.
The pro-apoptotic activity of Diablo is mainly controlled by its localization. Diablo is produced as a precursor protein and targeted to the mitochondria by an N-terminal targeting peptide, which is removed by proteolysis to localize Diablo to the inter-membrane space.5,6 The processed form is present in the mitochondria of healthy cells, as is cytochrome c, which when released can activate Apaf-1 in the cytosol, leading to activation of the apoptosome and caspases 9 and 3.5,6,19,20 Processing of Diablo produces an N-terminus beginning with the residues AVP that resembles the N-termini of Drosophila pro-apoptotic proteins Grim, Reaper and HID that are critical for their activity.11,12,13,14 As shown in Figure 8, over-expressed mDiablo detected by mouse specific 9H10 localizes to the mitochondria. Endogenous human Diablo in HeLa cells, detected by 10G7 had the same pattern of expression as seen in the transfected cells (data not shown). Following an apoptotic stimulus such as UV radiation, Diablo is released from the mitochondria into the cytoplasm.5,6 In the cytoplasm Diablo can interact with IAPs5,6 thereby preventing them from inhibiting activated caspases.21,22,23
The finding that Diablo is expressed differentially among various tissue types, and the lack of correlation between levels of Diablo mRNA and protein in the heart, raises the possibility that Diablo may be under transcription and post-translational control, in addition to being controlled by its localization within the mitochondria. Indeed, a recent publication suggests that the Diablo gene may be induced by the cytokine IFNγ.24
Materials and Methods
Expression constructs
Full-length mouse Diablo cDNA fused to a C-terminal HA (YPYDVPDYA) epitope tag (HA Diablo) subcloned into mammalian expression vector pcDNA3 as described previously6 was used for expression in the 293T cell line. A pEF BOS expression construct encoding untagged Diablo also described previously6 was used for expression in HeLa cells. To prepare recombinant protein, Diablo was expressed as a glutathione-S-transferase (GST) fusion protein. N-terminal deleted fragment (1–54) of mouse Diablo cDNA, encoding the processed form (without the mitochondrial targeting sequence), was sub-cloned into vector pGEX-6p-3 (Pharmacia) for production of GST-Diablo in E. coli BL21.
Protein expression and purification
GST-Diablo was expressed and purified according to the previously described procedure.25,26 Briefly, the recombinant GST-Diablo protein was expressed in E. coli BL21 (DE3) following IPTG induction. The cells were lysed and protein purified by affinity chromatography using glutathione sepharose (Pharmacia). While the sample was bound to the resin, the GST-tag was removed by overnight digestion with PreScission protease (Amersham Pharmacia). Soluble Diablo was recovered from the resin and further purified by size exclusion chromatography using a Superdex 200 column. Following the purification Diablo contained five additional residues (GPLGS) attached to its N-terminus. The purified recombinant Diablo was used to immunize the rats for production of monoclonal antibodies.
Immunization
Wistar rats were initially immunized by subcutaneous (s.c.) injection with 100 μg of purified recombinant Diablo mixed with complete Freund's adjuvant (Difco). Two subsequent boosts of the immunogen, resuspended in complete Freund's adjuvant (Difco), were injected s.c., 3 and 6 weeks after the initial injection. A final boost with recombinant Diablo dissolved in PBS was given intravenously (i.v.) and intraperitonealy (i.p.) after 4 weeks. Three days later, hybridomas were generated by fusing spleen cells from immunized rats with the SP2/0 myeloma cell line as previously described.27
Hybridoma screening for antibodies to Diablo
Hybridomas producing monoclonal antibodies to Diablo were identified and their isotype determined using a previously described screening strategy.27 Briefly, 293T cells were transiently transfected with vectors encoding HA-tagged Diablo. 5×105 transfected cells were fixed in 1% paraformaldehyde and plated into each well of 96well tissue culture plate (Becton Dickinson, CA, USA). The cells were washed, permeabilized with 0.3% saponin (Sigma) and incubated with 100 μl of hybridoma supernatants for 1 h on ice. Bound antibodies were revealed with fluorescein-isothiocyanate (FITC)-conjugated goat anti-rat IgG (H+L) secondary antibodies (Southern Biotechnology) and detected by FACScanTM(Becton Dickinson). Antibody to the HA epitope tag (Boehringer Mannheim) was used as positive control to detect efficiency of transfection of HA Diablo construct and compare the profile of the antibody producing clones.
Hybridomas producing antibodies to Diablo were cloned twice and adapted for growth in medium containing low serum. For production of large amounts of antibodies, hybridomas were cultured for several weeks in the miniPERM classic 12.5 kD bioreactors (VIVA SCIENCE). Antibodies were purified on a protein-G sepharose column (Pharmacia).
Tissue culture and transfections
The human embryonic carcinoma cell line 293T and mouse cell lines NIH3T3 and FDC-P1 were routinely grown in DME media supplemented with 10% FCS. FDC-P1 cells were also supplemented with IL-3. Human cell lines HeLa and Jurkat were grown in RPMI media supplemented with 10% FCS. These cell lines were used to detect endogenous Diablo by immunoprecipitation and Western analysis.
293T and HeLa cells were transfected with HA Diablo or untagged Diablo construct using EffecteneTM transfection reagent (Qiagen) following the manufacturer's instructions. Fortyeight hours after transfection, the cells were used for screening the hybridoma clones and/or examining the expression of transfected Diablo constructs by immunoprecipitation, immunofluorescence and Western analysis.
Western blotting and immunoprecipitation
Various mouse organs/tissues were excised, rinsed in PBS and immediately frozen in isopentane on dry ice before homogenizing in lysis buffer at 4°C according to the method described previously.28 Cell lysates were prepared from various cell lines or mouse tissues using cold lysis buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 10% Triton X-100, 10% glycerol, 2 mM EDTA and complete protease inhibitor cocktail obtained from Roche, Mannheim, Germany). The concentration of protein was determined using Bio-Rad protein assay reagent (Bio-Rad laboratories, NSW, Australia). These lysates were then used for Western blots or for immunoprecipitation. One hundred and fifty micrograms of total protein from various cell lines was used to detect endogenous Diablo by Western blot. A minimum of 300 μg of total mouse tissue protein per lane was required to detect endogenous Diablo by Western blot. Protein from the cell lysates (a minimum of 500 μg from tissue total protein) was immunoprecipitated with anti-Diablo 10G7 or 9H10 mAbs plus protein G-Sepharose for 1 h. After extensive washing the immunoprecipitated material was eluted by boiling in sodium dodecyl sulphate-polyacrylamide gel loading buffer. Protein samples were size-fractionated on polyacrylamide gels (Gradipore), and transferred to HybondTM-C extra membranes (Amersham Life Science) by electroblotting. Non-specific binding of antibodies to membranes was blocked by incubation in 10% skimmed milk or 10% horse serum made in PBS containing 0.05% Tween-20. The membranes were then probed with 10G7 or 9H10 followed by HRP labelled goat anti-rat IgG (Amersham Pharmacia or Southern Biotechnology). Bound antibodies were visualized by enhanced chemiluminescence (ECL) (Amersham Pharmacia). Transfected HA Diablo was used as a size control for most of the experiments. To control for the concentration and integrity of proteins in the tissue lysates, blots were reprobed with mouse anti-Hsp70 mAb (a gift from Dr. David Huang, The Walter and Eliza Hall Institute, Melbourne, Australia). The rabbit antiserum to Diablo/Smac was kindly provided to us by Dr. Xiaodong Wang.5
Tissue histochemistry
Tissue histochemistry procedures were based on online protocols (www.protocol-online.net/immuno/immunohisto/immunohistochemistry.htm). Freshly cut mouse tissues were fixed in Histochoice (Amresco, Solon, OH) for 1–3 h and processed for paraffin embedding followed by section cutting. Before staining the tissue sections were dewaxed and gradually rehydrated. Tissue sections were treated with 0.3% hydrogen peroxide in PBS to block the endogenous peroxidase activity. The cells were then permeabilized by incubation in 0.2% Triton X-100 and non-specific staining was prevented by incubation with 2.5% horse serum for 1 h at room temperature. Sections were incubated in a humidified chamber with 9H10 for 1 h at room temperature. After washing in PBS containing 0.2% Triton X-100, tissues were incubated with HRP conjugated goat anti-rat IgG (Amersham Pharmacia). To enhance the signal, the tissues were incubated with biotinylated goat anti-rat IgG (Southern Biotechnology). This was followed by incubating with ABC Vectastain elite reagent (Vector Laboratories, CA, USA) and finally the sections were stained with DAB reagent (Vector Laboratories, CA, USA) according to the manufacturer's instructions. Sections were counterstained with hematoxylin, and dehydrated in graded concentrations of alcohol and histolene before mounting in DPX (BDH, Poole, UK).
Immunofluorescence
HeLa cells were grown to about 30% confluency on cover slips followed by transient transfection with vectors encoding mouse Diablo. After 40 h cells were either exposed to UV (25 J/M2) to induce UV radiation-induced apoptosis or left unexposed. Seven hours later all cells were incubated with Mito Tracker red (Molecular Probes) for 15 min at 37°C to stain the mitochondria before fixing in Histochoice (Amresco, Solon, OH, USA) for 10 min. Expression of Diablo was detected using 9H10 for 1 h followed by FITC labelled goat anti-rat (Southern Biotechnology). Nuclei were stained by adding DAPI, for 30 min, together with the secondary antibody. Microscopy was performed on a confocal microscope (Leica Microsystems, Germany) visualizing mitochondria (as red), Diablo (as green) and nucleus (as blue).
Abbreviations
- mAbs:
-
monoclonal antibodies
- IAPs:
-
inhibitor of apoptosis proteins
- BIR:
-
baculoviral IAP repeat
- s.c:
-
subcutaneous
- i.p:
-
intraperitonealy
- i.v:
-
intravenously
- FITC:
-
fluorescein-isothiocyanate
- HA:
-
epitope (YPYDVPDYA) tag
- HA Diablo:
-
epitope HA-tagged Diablo protein
- IP:
-
immunoprecipitation
- IF:
-
immunofluorescence
- WB:
-
Western blotting
- FACS:
-
fluorescence-activated cell sorter
References
Hay BA, Wassarman DA, Rubin GM . 1995 Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death Cell 83: 1253–1262
Kaiser WJ, Vucic D, Miller LK . 1998 The Drosophila inhibitor of apoptosis D-IAP1 suppresses cell death induced by the caspase drICE FEBS Lett. 440: 243–248
Wang SL, Hawkins CJ, Yoo SJ, Muller HA, Hay BA . 1999 The Drosophila caspase inhibitor DIAP1 is essential for cell survival and is negatively regulated by HID Cell 98: 453–463
Song Z, Guan B, Bergman A, Nicholson DW, Thornberry NA, Peterson EP, Steller H . 2000 Biochemical and genetic interactions between Drosophila caspases and the proapoptotic genes Rpr, Hid, and Grim Mol. Cell. Biol. 20: 2907–2914
Du C, Fang M, Li Y, Li L, Wang X . 2000 Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 102: 33–42
Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, Vaux DL . 2000 Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins Cell 102: 43–53
Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM, Day CL, Tikoo A, Burke R, Wrobel C, Moritz RL, Simpson RJ, Vaux DL . 2002 HtrA2 promotes cell death through its serine protease activity and its ability to antagonise inhibitor of apoptosis proteins J. Biol. Chem. 277: 445–454
Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R . 2001 A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death Mol. Cell 8: 613–621
Hegde R, Srinivasula SM, Zhang Z, Wassell R, Mukattash R, Cilenti L, DuBois G, Lazebnik Y, Zervos AS, Fernandes-Alnemri T, Alnemri ES . 2002 Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts IAP-caspase interaction J. Biol. Chem. 277: 432–438
Martins LM, Iaccarino I, Tenev T, Gschmeissner S, Totty NF, Lemoine NR, Savopoulos J, Gray CW, Creasy CL, Dingwall C, Downward J . 2002 The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a Reaper-like motif J. Biol. Chem. 277: 439–444
Chai J, Du C, Wu JW, Kyin S, Wang X, Shi Y . 2000 Structural and biochemical basis of apoptotic activation by Smac/DIABLO Nature 406: 855–862
Liu Z, Sun C, Olejniczak ET, Meadows RP, Betz SF, Oost T, Herrman J, Wu JC, Fesik SW . 2000 Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain Nature 408: 1004–1008
Silke J, Verhagen AM, Ekert PG, Vaux DL . 2000 Sequence as well as functional similarity for DIABLO/Smac and Grim, Reaper and Hid? Cell Death Differ. 7: 1275
Wu G, Chai J, Suber TL, Wu JW, Du C, Wang X, Shi Y . 2000 Structural basis of IAP recognition by Smac/DIABLO Nature 408: 1008–1012
Ekert PG, Silke J, Hawkins CJ, Verhagen AM, Vaux DL . 2001 DIABLO promotes apoptosis by removing MIHA/XIAP from processed caspase 9 J. Cell Biol. 152: 483–490
Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang Z, Alnemri ES . 2000 Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway J. Biol. Chem. 275: 36152–36157
Hasegawa M, Wilson G, Russell LD, Meistrich ML . 1997 Radiation-induced cell death in the mouse testis: relationship to apoptosis Radiat. Res. 147: 457–467
Moreno SG, Dutrillaux B, Coffigny H . 2001 High sensitivity of rat foetal germ cells to low dose-rate irradiation Int. J. Radiat. Biol. 77: 529–538
Adrain C, Martin SJ . 2001 The mitochondrial apoptosome: a killer unleashed by the cytochrome seas Trends Biochem. Sci. 26: 390–397
Abu-Qare AW, Abou-Donia MB . 2001 Biomarkers of apoptosis: release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2′-deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene J. Toxicol. Environ. Health B. Crit. Rev. 4: 313–332
Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC . 1997 The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases EMBO J. 16: 6914–6925
Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS, Reed JC . 1998 A single BIR domain of XIAP sufficient for inhibiting caspases J. Biol. Chem. 273: 7787–7790
Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC . 1999 Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases EMBO J. 18: 5242–5251
Yoshikawa H, Nakajima Y, Tasaka K . 2001 IFN-gamma Induces the Apoptosis of WEHI 279 and Normal Pre-B Cell Lines by Expressing Direct Inhibitor of Apoptosis Protein Binding Protein with Low pI J. Immunol. 167: 2487–2495
Hinds MG, Norton RS, Vaux DL, Day CL . 1999 Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat Nat. Struct. Biol. 6: 648–651
Day CL, Dupont C, Lackmann M, Vaux DL, Hinds MG . 1999 Solution structure and mutagenesis of the caspase recruitment domain (CARD) from Apaf-1 Cell Death Differ. 6: 1125–1132
O'Reilly LA, Cullen L, Moriishi K, O'Connor L, Huang DC, Strasser A . 1998 Rapid hybridoma screening method for the identification of monoclonal antibodies to low-abundance cytoplasmic proteins Biotechniques 25: 824–830
Print CG, Loveland KL, Gibson L, Meehan T, Stylianou A, Wreford N, de Kretser D, Metcalf D, Kontgen F, Adams JM, Cory S . 1998 Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant Proc. Natl. Acad. Sci. USA 95: 12424–12431
Acknowledgements
We would like to acknowledge L Cullen and K Davern for assistance with antibody production, V Lapatis for assistance with confocal microscopy, Dr. D Huang for providing valuable reagents and Dr(s). A Strasser, J Silke and PG Ekert for valuable technical advice. This work was supported by an NHMRC grant to the WEHI (Reg Key 973002) and by the Anti-Cancer Council of Victoria. DL Vaux is a scholar of the Leukemia and Lymphoma Society.
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by G Cohen
Rights and permissions
About this article
Cite this article
Tikoo, A., O'Reilly, L., Day, C. et al. Tissue distribution of Diablo/Smac revealed by monoclonal antibodies. Cell Death Differ 9, 710–716 (2002). https://doi.org/10.1038/sj.cdd.4401031
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4401031
Keywords
This article is cited by
-
Synthetic Smac peptide enhances the effect of etoposide-induced apoptosis in human glioblastoma cell lines
Journal of Neuro-Oncology (2006)
-
SMAC is expressed de novoin a subset of cervical cancer tumors
BMC Cancer (2004)